Intrinsic value of Sientra - SIEN

Previous Close

$18.98

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$18.98

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of SIEN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  58
  90
  135
  196
  277
  380
  510
  670
  862
  1,089
  1,352
  1,653
  1,993
  2,371
  2,788
  3,243
  3,736
  4,265
  4,831
  5,431
  6,066
  6,734
  7,436
  8,170
  8,937
  9,737
  10,569
  11,436
  12,337
  13,273
Variable operating expenses, $m
  137
  210
  313
  452
  637
  875
  1,173
  1,539
  1,980
  2,500
  3,100
  3,790
  4,568
  5,435
  6,391
  7,434
  8,564
  9,778
  11,074
  12,450
  13,905
  15,437
  17,045
  18,728
  20,486
  22,319
  24,228
  26,215
  28,280
  30,427
Fixed operating expenses, $m
  12
  13
  13
  13
  13
  14
  14
  14
  15
  15
  15
  16
  16
  16
  17
  17
  17
  18
  18
  19
  19
  19
  20
  20
  21
  21
  22
  22
  23
  23
Total operating expenses, $m
  149
  223
  326
  465
  650
  889
  1,187
  1,553
  1,995
  2,515
  3,115
  3,806
  4,584
  5,451
  6,408
  7,451
  8,581
  9,796
  11,092
  12,469
  13,924
  15,456
  17,065
  18,748
  20,507
  22,340
  24,250
  26,237
  28,303
  30,450
Operating income, $m
  -91
  -132
  -191
  -270
  -374
  -508
  -677
  -883
  -1,132
  -1,425
  -1,763
  -2,152
  -2,591
  -3,081
  -3,620
  -4,208
  -4,845
  -5,530
  -6,261
  -7,037
  -7,858
  -8,722
  -9,629
  -10,578
  -11,570
  -12,604
  -13,681
  -14,801
  -15,966
  -17,176
EBITDA, $m
  -85
  -125
  -181
  -257
  -358
  -487
  -649
  -849
  -1,088
  -1,371
  -1,699
  -2,074
  -2,498
  -2,969
  -3,488
  -4,055
  -4,669
  -5,329
  -6,033
  -6,781
  -7,572
  -8,405
  -9,279
  -10,194
  -11,149
  -12,145
  -13,183
  -14,262
  -15,385
  -16,551
Interest expense (income), $m
  0
  2
  6
  12
  19
  30
  44
  62
  84
  112
  145
  184
  229
  281
  340
  405
  477
  555
  640
  731
  829
  932
  1,042
  1,157
  1,278
  1,404
  1,536
  1,674
  1,818
  1,967
  2,122
Earnings before tax, $m
  -93
  -139
  -202
  -289
  -404
  -552
  -738
  -967
  -1,244
  -1,570
  -1,947
  -2,381
  -2,872
  -3,420
  -4,024
  -4,685
  -5,400
  -6,170
  -6,992
  -7,866
  -8,790
  -9,764
  -10,786
  -11,856
  -12,974
  -14,140
  -15,355
  -16,619
  -17,933
  -19,299
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -93
  -139
  -202
  -289
  -404
  -552
  -738
  -967
  -1,244
  -1,570
  -1,947
  -2,381
  -2,872
  -3,420
  -4,024
  -4,685
  -5,400
  -6,170
  -6,992
  -7,866
  -8,790
  -9,764
  -10,786
  -11,856
  -12,974
  -14,140
  -15,355
  -16,619
  -17,933
  -19,299

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  144
  223
  334
  484
  683
  939
  1,260
  1,655
  2,129
  2,689
  3,339
  4,082
  4,921
  5,855
  6,884
  8,008
  9,224
  10,532
  11,928
  13,410
  14,978
  16,628
  18,360
  20,173
  22,066
  24,041
  26,097
  28,237
  30,461
  32,774
Adjusted assets (=assets-cash), $m
  144
  223
  334
  484
  683
  939
  1,260
  1,655
  2,129
  2,689
  3,339
  4,082
  4,921
  5,855
  6,884
  8,008
  9,224
  10,532
  11,928
  13,410
  14,978
  16,628
  18,360
  20,173
  22,066
  24,041
  26,097
  28,237
  30,461
  32,774
Revenue / Adjusted assets
  0.403
  0.404
  0.404
  0.405
  0.406
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
  0.405
Average production assets, $m
  23
  35
  53
  77
  108
  149
  200
  262
  337
  426
  529
  646
  779
  927
  1,090
  1,268
  1,461
  1,668
  1,889
  2,124
  2,372
  2,633
  2,907
  3,194
  3,494
  3,807
  4,133
  4,471
  4,824
  5,190
Working capital, $m
  5
  8
  12
  17
  24
  33
  45
  59
  76
  96
  119
  145
  175
  209
  245
  285
  329
  375
  425
  478
  534
  593
  654
  719
  786
  857
  930
  1,006
  1,086
  1,168
Total debt, $m
  62
  117
  194
  299
  438
  616
  840
  1,116
  1,447
  1,838
  2,292
  2,810
  3,396
  4,048
  4,766
  5,550
  6,400
  7,312
  8,286
  9,321
  10,415
  11,567
  12,776
  14,041
  15,363
  16,741
  18,177
  19,670
  21,223
  22,837
Total liabilities, $m
  101
  156
  233
  338
  477
  655
  880
  1,155
  1,486
  1,877
  2,331
  2,850
  3,435
  4,087
  4,805
  5,589
  6,439
  7,351
  8,326
  9,360
  10,454
  11,606
  12,815
  14,081
  15,402
  16,781
  18,216
  19,709
  21,262
  22,876
Total equity, $m
  44
  67
  101
  146
  206
  283
  381
  500
  643
  812
  1,008
  1,233
  1,486
  1,768
  2,079
  2,418
  2,786
  3,181
  3,602
  4,050
  4,523
  5,022
  5,545
  6,092
  6,664
  7,260
  7,881
  8,528
  9,199
  9,898
Total liabilities and equity, $m
  145
  223
  334
  484
  683
  938
  1,261
  1,655
  2,129
  2,689
  3,339
  4,083
  4,921
  5,855
  6,884
  8,007
  9,225
  10,532
  11,928
  13,410
  14,977
  16,628
  18,360
  20,173
  22,066
  24,041
  26,097
  28,237
  30,461
  32,774
Debt-to-equity ratio
  1.420
  1.730
  1.920
  2.040
  2.120
  2.170
  2.210
  2.230
  2.250
  2.260
  2.270
  2.280
  2.280
  2.290
  2.290
  2.300
  2.300
  2.300
  2.300
  2.300
  2.300
  2.300
  2.300
  2.300
  2.310
  2.310
  2.310
  2.310
  2.310
  2.310
Adjusted equity ratio
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -93
  -139
  -202
  -289
  -404
  -552
  -738
  -967
  -1,244
  -1,570
  -1,947
  -2,381
  -2,872
  -3,420
  -4,024
  -4,685
  -5,400
  -6,170
  -6,992
  -7,866
  -8,790
  -9,764
  -10,786
  -11,856
  -12,974
  -14,140
  -15,355
  -16,619
  -17,933
  -19,299
Depreciation, amort., depletion, $m
  6
  7
  9
  12
  16
  21
  27
  35
  44
  54
  64
  78
  94
  112
  131
  153
  176
  201
  228
  256
  286
  317
  350
  385
  421
  459
  498
  539
  581
  625
Funds from operations, $m
  -88
  -131
  -193
  -277
  -388
  -531
  -711
  -933
  -1,200
  -1,516
  -1,883
  -2,304
  -2,779
  -3,308
  -3,893
  -4,532
  -5,224
  -5,969
  -6,765
  -7,610
  -8,504
  -9,446
  -10,435
  -11,471
  -12,553
  -13,682
  -14,857
  -16,080
  -17,352
  -18,673
Change in working capital, $m
  2
  3
  4
  5
  7
  9
  11
  14
  17
  20
  23
  26
  30
  33
  37
  40
  43
  47
  50
  53
  56
  59
  62
  65
  67
  70
  73
  76
  79
  82
Cash from operations, $m
  -89
  -134
  -197
  -282
  -395
  -540
  -722
  -947
  -1,217
  -1,536
  -1,906
  -2,330
  -2,808
  -3,342
  -3,930
  -4,572
  -5,268
  -6,016
  -6,814
  -7,663
  -8,560
  -9,505
  -10,497
  -11,536
  -12,621
  -13,752
  -14,930
  -16,156
  -17,431
  -18,756
Maintenance CAPEX, $m
  -2
  -3
  -4
  -6
  -9
  -13
  -18
  -24
  -32
  -41
  -51
  -64
  -78
  -94
  -112
  -131
  -153
  -176
  -201
  -228
  -256
  -286
  -317
  -350
  -385
  -421
  -459
  -498
  -539
  -581
New CAPEX, $m
  -8
  -12
  -18
  -24
  -31
  -41
  -51
  -62
  -75
  -89
  -103
  -118
  -133
  -148
  -163
  -178
  -193
  -207
  -221
  -235
  -248
  -261
  -274
  -287
  -300
  -313
  -326
  -339
  -352
  -366
Cash from investing activities, $m
  -10
  -15
  -22
  -30
  -40
  -54
  -69
  -86
  -107
  -130
  -154
  -182
  -211
  -242
  -275
  -309
  -346
  -383
  -422
  -463
  -504
  -547
  -591
  -637
  -685
  -734
  -785
  -837
  -891
  -947
Free cash flow, $m
  -100
  -149
  -218
  -312
  -435
  -594
  -791
  -1,033
  -1,323
  -1,665
  -2,060
  -2,511
  -3,019
  -3,583
  -4,205
  -4,881
  -5,613
  -6,399
  -7,236
  -8,125
  -9,064
  -10,052
  -11,089
  -12,173
  -13,305
  -14,486
  -15,714
  -16,993
  -18,322
  -19,703
Issuance/(repayment) of debt, $m
  37
  55
  77
  105
  139
  179
  224
  275
  331
  391
  454
  519
  585
  652
  719
  784
  849
  913
  974
  1,035
  1,094
  1,152
  1,209
  1,265
  1,322
  1,378
  1,435
  1,493
  1,553
  1,614
Issuance/(repurchase) of shares, $m
  109
  162
  236
  334
  464
  629
  835
  1,087
  1,387
  1,739
  2,143
  2,606
  3,126
  3,702
  4,335
  5,024
  5,768
  6,565
  7,414
  8,314
  9,263
  10,262
  11,309
  12,403
  13,546
  14,737
  15,976
  17,265
  18,605
  19,997
Cash from financing (excl. dividends), $m  
  146
  217
  313
  439
  603
  808
  1,059
  1,362
  1,718
  2,130
  2,597
  3,125
  3,711
  4,354
  5,054
  5,808
  6,617
  7,478
  8,388
  9,349
  10,357
  11,414
  12,518
  13,668
  14,868
  16,115
  17,411
  18,758
  20,158
  21,611
Total cash flow (excl. dividends), $m
  47
  68
  94
  127
  167
  214
  268
  329
  395
  465
  536
  613
  692
  771
  849
  927
  1,004
  1,079
  1,152
  1,223
  1,293
  1,362
  1,429
  1,496
  1,562
  1,629
  1,697
  1,765
  1,835
  1,908
Retained Cash Flow (-), $m
  -109
  -162
  -236
  -334
  -464
  -629
  -835
  -1,087
  -1,387
  -1,739
  -2,143
  -2,606
  -3,126
  -3,702
  -4,335
  -5,024
  -5,768
  -6,565
  -7,414
  -8,314
  -9,263
  -10,262
  -11,309
  -12,403
  -13,546
  -14,737
  -15,976
  -17,265
  -18,605
  -19,997
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -63
  -94
  -141
  -207
  -297
  -415
  -567
  -758
  -992
  -1,274
  -1,607
  -1,993
  -2,434
  -2,932
  -3,486
  -4,097
  -4,764
  -5,486
  -6,262
  -7,090
  -7,970
  -8,900
  -9,880
  -10,908
  -11,984
  -13,107
  -14,279
  -15,499
  -16,769
  -18,089
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  -60
  -86
  -123
  -171
  -230
  -301
  -383
  -474
  -570
  -668
  -763
  -850
  -925
  -984
  -1,023
  -1,041
  -1,037
  -1,010
  -964
  -901
  -824
  -739
  -648
  -556
  -466
  -382
  -306
  -240
  -183
  -136
Current shareholders' claim on cash, %
  71.6
  52.2
  38.7
  29.0
  22.0
  16.9
  13.0
  10.1
  7.9
  6.3
  4.9
  3.9
  3.1
  2.5
  2.0
  1.6
  1.3
  1.1
  0.9
  0.7
  0.6
  0.5
  0.4
  0.3
  0.3
  0.2
  0.2
  0.1
  0.1
  0.1

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth. The Company also offers miraDry system, the device to reduce underarm sweat, odor and permanently reduce hair of all colors.

FINANCIAL RATIOS  of  Sientra (SIEN)

Valuation Ratios
P/E Ratio -8.8
Price to Sales 16.8
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow -10.4
Price to Free Cash Flow -10.1
Growth Rates
Sales Growth Rate -44.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 0%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets -31.4%
Ret/ On Assets - 3 Yr. Avg. -21.1%
Return On Total Capital -39.4%
Ret/ On T. Cap. - 3 Yr. Avg. -27%
Return On Equity -39.4%
Return On Equity - 3 Yr. Avg. -29.2%
Asset Turnover 0.2
Profitability Ratios
Gross Margin 66.7%
Gross Margin - 3 Yr. Avg. 70.4%
EBITDA Margin -185.7%
EBITDA Margin - 3 Yr. Avg. -99.1%
Operating Margin -190.5%
Oper. Margin - 3 Yr. Avg. -102.1%
Pre-Tax Margin -190.5%
Pre-Tax Margin - 3 Yr. Avg. -103.9%
Net Profit Margin -190.5%
Net Profit Margin - 3 Yr. Avg. -103.9%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

SIEN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SIEN stock intrinsic value calculation we used $36.542 million for the last fiscal year's total revenue generated by Sientra. The default revenue input number comes from 0001 income statement of Sientra. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SIEN stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for SIEN is calculated based on our internal credit rating of Sientra, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Sientra.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SIEN stock the variable cost ratio is equal to 237.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $12 million in the base year in the intrinsic value calculation for SIEN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 10% for Sientra.

Corporate tax rate of 27% is the nominal tax rate for Sientra. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SIEN stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SIEN are equal to 39.1%.

Life of production assets of 8.3 years is the average useful life of capital assets used in Sientra operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SIEN is equal to 8.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $27.623 million for Sientra - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 28.428 million for Sientra is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Sientra at the current share price and the inputted number of shares is $0.5 billion.

RELATED COMPANIES Price Int.Val. Rating
MDXG MiMedx Group 6.22 5.77  buy
JNJ Johnson&Johnso 144.50 176.79  buy
CUTR Cutera 21.20 38.15  hold
SSKN Strata Skin Sc 2.63 0.02  str.sell

COMPANY NEWS

▶ Sientra: 3Q Earnings Snapshot   [05:11PM  Associated Press]
▶ Sientra to Participate in Upcoming Investor Conferences   [Oct-31-18 04:01PM  GlobeNewswire]
▶ Sientra: 2Q Earnings Snapshot   [Aug-07-18 05:38PM  Associated Press]
▶ Sientra, Inc. to Host Earnings Call   [02:30PM  ACCESSWIRE]
▶ Sientra to Launch State-of-the-Art Innovation Facility   [Jul-31-18 08:00AM  PR Newswire]
▶ Sientra: 1Q Earnings Snapshot   [May-09-18 05:18PM  Associated Press]
▶ Sientra Commences Public Offering of Common Stock   [Apr-30-18 07:01AM  GlobeNewswire]
▶ Sientra Receives FDA Approval of PMA Supplement   [Apr-18-18 04:01PM  GlobeNewswire]
▶ Sientra reports 4Q loss   [Mar-13-18 04:19PM  Associated Press]
▶ Sientra, Inc. to Host Earnings Call   [12:00PM  ACCESSWIRE]
▶ ETFs with exposure to Sientra, Inc. : December 7, 2017   [Dec-07-17 02:30PM  Capital Cube]
▶ Sientra reports 3Q loss   [Nov-07-17 05:03PM  Associated Press]
▶ Sientra, Inc. to Host Earnings Call   [10:10AM  ACCESSWIRE]
▶ Sientra® to Release Third Quarter 2017 Financial Results   [Nov-03-17 08:01AM  GlobeNewswire]
▶ ETFs with exposure to Sientra, Inc. : November 2, 2017   [Nov-02-17 12:33PM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : October 16, 2017   [Oct-16-17 09:59AM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : October 2, 2017   [Oct-02-17 11:06AM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : September 19, 2017   [Sep-19-17 06:31PM  Capital Cube]
▶ Sientra reports 2Q loss   [Aug-09-17 04:38PM  Associated Press]
▶ Sientra Announces Settlement of Lawsuit   [Aug-01-17 08:30AM  GlobeNewswire]
▶ Sientra Completes Acquisition of Miramar Labs®   [Jul-26-17 08:30AM  GlobeNewswire]
▶ Sientra to Acquire Miramar Labs®   [Jun-12-17 08:00AM  GlobeNewswire]
▶ ETFs with exposure to Sientra, Inc. : May 30, 2017   [May-30-17 12:43PM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : May 15, 2017   [May-15-17 04:38PM  Capital Cube]
▶ Sientra reports 1Q loss   [May-09-17 05:50PM  Associated Press]
▶ ETFs with exposure to Sientra, Inc. : April 7, 2017   [Apr-07-17 05:28PM  Capital Cube]
▶ FDA Links Breast Implants To A Rare Form Of Cancer   [Mar-21-17 05:26PM  Benzinga]
▶ Sientra reports 4Q loss   [Mar-14-17 04:50PM  Associated Press]
▶ Here is What Hedge Funds Think About Sientra Inc (SIEN)   [Dec-14-16 12:54PM  at Insider Monkey]
▶ Sientra to Present at Investor Conferences in November 2016   [Nov-10-16 08:30AM  GlobeNewswire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.